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Aim: Study is devoted to evaluation of sensitivity of peripheral blood T-lymphocytes (PBL) of patients with endometrial cancer (EC) 
to genotoxic effect of bleomycin and detection of patients with hidden chromosomal instability. Methods: PBL of 24 EC patients 
(mean age 58.9 ± 2.9) and 10 healthy women-volunteers (mean age 55.7 ± 2.3) were subjected to cytogenetic analysis. 
Results: Mean spontaneous level of chromosomal aberrations (CA) per 100 analyzed lymphocytes (CA/100) of healthy women has 
equaled 2.7 ± 0.6, i.e. has not exceeded maximal values of healthy population and was significantly lower (p < 0.05), than in PBL 
of EC patients (6.9 ± 0.6). After incubation of PBL with bleomycin, number of CA/100 significantly was increased both in control 
(11.5 ± 1.3) and in EC patients (21.9 ± 1.0). Spontaneous chromosomal instability has been observed in 41.7%, increased sen-
sitivity to bleomycin — in 54.2% and hidden chromosomal instability in 37.5% of patients with EC. It has been shown that level 
of specific damage of genome in EC patients has constituted 2·10–5, and after exposure with bleomycin, it was increased 4.5 times 
(9·10–5) that was significantly higher (p < 0.05) compared to control (8·10–6 and 1.0·10–5, respectively). Conclusion: These results 
have demonstrated that PBL of most patients with EC are characterized by apparent genome alterations, which are manifested 
by increased number of spontaneous and induced chromosomal damages, hypersensitivity to mutagens and hidden chromosomal instability.
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Searching for genetic markers, which would allow 
detecting individuals with predisposition to cancer 
and identifying tumor in its initial stages, is urgent 
task of modern oncology. Number of reports showed 
changes of immune status in cancer patients, inclu-
ding decrease of T-lymphocytes activity due to inhibi-
ting effect of tumor and genetic defects of compo-
nents of immune system [1]. Chromosomal instability 
in peripheral blood lymphocytes (PBL) is the evidence 
of disorder in genome and, first of all, imperfection 
of functioning of DNA reparation genes. It is typical for 
many solid tumors, including endometrial cancer (EC), 
development of which is connected with mutations 
or epigenetically caused changes of genes, which are 
responsible for reparation of unpaired bases of DNA — 
genes of MMR family and genes-regulators of cell 
cycle: PTEN, PIK3, KRAS, BRAF, etc. [2].
According to the results of our previous studies, 
increase of mean spontaneous level of chromosomal 
aberrations (CA) in PBL of patients with EC com-
pared with healthy women is observed [4]. However, 
analysis of individual parameters has determined 
patients with low frequency of cells with CA, which 
have not exce eded maximal values of healthy popula-
tion (3.0%)  [ 4–6]. If we hold the view that individuals 
with hidden chromosomal instability exist [7, 8], than 
we can assume that patients with EC are divided into 
two groups — with existing and hidden chromosomal 
instability, which probably plays certain role in patho-
genesis of disease. Increased number of spontane-
ous damages of chromosomes in PBL, hypersensiti-
vity to the impact of mutagenic factors and hidden 
chromosomal instability are signs of destabilization 
of genome [3, 7–9], study of which becomes more 
urgent for detection of individuals susceptible to de-
velopment of malignant tumors, formation of groups 
of genetic risk of cancer pathology and further moni-
toring of woman health.
For imitation of impact of hazardous factors on cell 
genome, various mutagens are used, among which 
most widespread and offered for use in such studies 
(in many countries of the world, including Ukraine) 
is bleomycin [8, 10, 11]. Mechanism of bleomycin ef-
fect is similar to the effect of many mutagens of physi-
cal and chemical nature (for example, ioni zing radia-
tion or hydrogen peroxide) and is connected with oc-
currence of oxidative stress, in consequence of which 
active oxygen forms cause occurrence of single and 
double strand breaks of DNA. The highest activity 
is performed by bleomycin, when it impacts cells being 
in phase G2 of mitotic cycle [8, 10–12].
We designed this study to evaluate the sensitivity 
of EC patients’ PBL to genotoxic effect of bleomycin and 
detect the patients with hidden chromosome instability.
MATERIALS AND METHODS
PBL were studied from 24 patients with EC in age 
from 48 to 67 (mean age 58.9 ± 2.9), which underwent 
the treatment at the department of Oncogynecology 
at the National Cancer Institute of Ministry of Health 
of Ukraine (The head of the Department — M.D., 
Prof. L.I. Vorobyova). Blood from vein was received 
from patients before surgical treatment and chemo-
therapy. 10 healthy women-volunteers in the age from 
23 to 64 (mean age 55.7 ± 2.3) were included in control 
group. All patients have given informed consent for 
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blood sampling, cytogenetic studies and use of the re-
sults for research goals.
To study the spontaneous level of CA in PBL of pa-
tients, whole heparinized venous blood (1.0 ml) has been 
cultivated during 52 hrs, according to the recommen-
dations [13] with some modifications. For evaluation 
of sensitivity of chromosomes to the impact of muta-
gen, PBL of patients with EC and healthy women have 
been cultivated during 72 h with adding of bleomycin 
hydrochloride solution on 48 hour of cultivation in final 
concentration 5 μg/ml [8, 11]. Fixing of specimens and 
receiving of metaphase chromosomes has been carried 
out by standard method. Staining of specimens has been 
performed by Giemsa-trypsin method [13].
Cytogenetic analysis of PBL has been carried out 
on codified specimens of chromosomes using of light 
microscope at magnification x1250 (oil immersion). Num-
ber of analyzed metaphases varied from 50 to 200 in each 
observation. At cytogenetic analysis, number of meta-
phases with CA, number of CA per 100 metaphases 
(CA/100) and per 1 aberrant metaphase were calculated. 
Also types of CA — chromatid and chromosome bre-
akage were characterized: single acentric fragments and 
chromatid-chromatid exchanges, paired acentric frag-
ments, dicentrics, rings, marker chromosomes, breaks 
of chromosomes by centromere. Separately localization 
of aberrations on chromosome has been determined.
Moreover, for taking into account the number of CA, 
which were determined in particular chromosomes 
in different groups of karyotype, specific damage-
ability of particular chromosomes (number of points 
of damage on group of examined chromosomes) and 
specific damageability of genome damage, have been 
calculated: (Wі-chromosome) and (Wgenome) [14].
Specific damageability of particular chromosomes 
has been calculated by formula: 
Wі-chromosome = (n1/N1+....ni/Ni)/LI, (1)
where ni — number of damages in concrete 
chromosome in і-patient; Ni — number of analyzed 
metaphase plates in і-patient; L — relative length 
of chromosome [15]; I — number of patients.
For comparison of level of chromosome damage 
in groups of women-volunteers and EC patients, spe-
cific damageability of genome damage by formula has 
been determined: 
Wgenome = (W1-chromosome +.....+W23-chromosome)/23. (2)
By level of chromosome damage, conclusions 
concerning spontaneous and induced instability of ge-
nome and hypersensitivity of chromosomes to the ef-
fect of mutagen have been made, calculating index 
mentioned below [11].
Index of spontaneous chromosomal instability (Isci) 
has been calculated by formula: 
Isci = Msci/M, (3)
where Msci — individual values of spontaneous 
frequency of CA, and M — mean group value of sponta-
neous frequency of CA. Index of induced chromosomal 
instability (Iici) has been determined by formula: 
Iici = Mici/M, (4)
where Mici — individual values of frequency of CA un-
der the effect of bleomycin; M — mean group values 
of CA under the effect of bleomycin. Hypersensitive 
to bleomycin at that were considered all patients with Iici 
higher, than 1.0 (independently from Isci). Patients with 
Isci lower than 1.0, and Iici — higher than 1.0 — were 
considered to have hidden chromosome instability in PBL.
Statistical analysis of results has been carried out 
using Statistica 6.0 (StatSoft, Inc.) with use of non-
parametric criterion of Wilkinson — Mann — Whitney. 
Significant were considered diffe rences at р < 0.05.
RESULTS AND DISCUSSION
Spontaneous level of CA/100 in control varied from 
1.0 to 4.0 and equaled at the mean to 2.7 ± 0.6, i.e. 
has not exceeded mean values in healthy population 
(Table 1).
Table 1. Cytogenetic changes in PBL of healthy women and EC patients
Cytogenetic parameters
Control (n = 10) EC patients (n = 24)
Spon-
taneous 
level
Induced 
level
Spon-
taneous 
level
Induced 
level
Number of cells with CA, М ± m, % 2.6±0.6 9.3±1.2^ 5.7±0.2* 13.4±0.9*^
Number of CA/100 cells, М ± m
including:
2.7±0.6 11.5±1.3^ 6.9±0.6* 21.9±1.0*^
number of chromatid CA, % 74.1 56.5 62.2 65.8
number of chromosome CA, % 25.9 43.5 37.8 34.2
Number of CA per 1 aber-
rant cell 1.0 1.2 1.2 1.6
Note: *difference between indexes in patients with EC and in control is sig-
nificant (р < 0.05); ^ difference between indexes of spontaneous and induced 
levels of CA is significant (р < 0.05).
In contrast, in PBL of EC patients, spontaneous 
level of CA/100 was significantly (р < 0.05) higher, than 
in healthy population and in control, and has constituted 
6.9 ± 0.6. In all studied specimens, aberrations of chroma-
tid type prevailed and mostly were represented by single 
acentric fragments of chromosomes. It should be men-
tioned that individual values of spontaneous frequency 
of CA/100 in PBL of patients with EC varied in wider range 
(from 2.0–26.0). At that Isci in metaphases of EC patients 
varied from 0.3 to 3.8 and in 41.7% of patients was higher, 
than 1.0 that is the evidence of presence of spontaneous 
chromosome instability in these patients. At the same 
time, Isci in control was mostly lower, than 1.0 and only 
in one patient it has constituted 1.5.
Undoubtedly important criterion for determination 
of cytogenetic changes in cells is evaluation of PBL 
sensitivity to mutagenic impact of alkylating substances, 
in particular, bleomycin. After incubation of PBL cultures 
with bleomycin, frequency of aberrant cells and number 
of CA/100 reliably (р < 0.05) increased both in healthy 
women and in EC patients. In patients with EC, higher 
number of CA/100 (21.9 ± 1.0, at individual variations 
from 17.0 to 44.0), than in healthy women (11.5 ± 1.3, 
at individual variations 7.0–19.0) was observed. At the 
same time, in PBL of healthy women, number of chro-
matid aberrations has decreased and number of aber-
rations associated with damage of chromosomes has 
increased. In PBL of patients with EC, after incubation 
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with bleomycin, these indexes have almost not changed 
(see Table 1). According to the data of literature [8, 10], 
bleomycin is a substance, which, the same as ionizing 
irradiation, causes occurrence of aberrations of chro-
mosome type, but presence in analyzed cultures of high 
percentage of chromatid aberrations can be the evi-
dence of its action as both radiomimetic and chemical 
mutagen.
Besides mentioned above, according to the re-
cent studies, presence in PBL of certain quantity 
of CA of chromatid and chromosome types depends 
not only on parameters of active substance, but mostly 
on polymorphism of series of genes of excisional repa-
ration of DNA bases [16]. In particular, authors showed 
that in group of studied children, who lived in the condi-
tions of chronic impact of radon, higher level of aber-
rations of chromatid type in carriers of genotype АРЕ 
148Glu/Glu (4.58 ± 0.41; p = 0.045), than in individuals 
with genotype APE1 Asp/Asp (3.67 ± 0.33) has been de-
termined. In the same study, decrease of total frequency 
of CA in carriers of heterozygote XRCC1 280 Arg/His 
of genotype (4.55 ± 0.57; p = 0.04) compared with 
Arg/Arg genotype (5.59 ± 0.22) has been determined.
In our opinion, detected high level of spontaneous 
and hidden chromosomal instability in patients with 
EC is also result of disorder of functioning of systems 
of DNA reparation that can be one of the reasons 
of development in these patients of cancer disease. 
This assumption can be confirmed by the study 
of effectiveness of DNA reparation (method of ge l-e-
lectrophoresis of isolated cells), which has been previ-
ously performed by us in this group of patients. It has 
been determined that after processes of reparation 
in PBL of EC patients, 63.9 ± 20.9% of DNA damages 
(in control — 80.2 ± 3.0%) have been repaired [17].
Analysis of PBL genome destabilization under 
the effect of bleomycin, which was evaluated by corre-
sponding coefficients, has determined that increased 
sensitivity to bleomycin is observed in 54.2% of pa-
tients with EC (Iici > 1.0, at individual variations of Iici 
from 1.2 to 2.4) and hidden chromosome instability 
has been detected in 37.5% of cases (at Isci < 1.0, Iici 
> 1.0) (Table 2, Fig. 1).
Table 2. Distribution of patients by rates of spontaneous chromosomal in-
stability in PBL
Groups 
of patients
Number of patients, %
Isci Iici Isci 
<1.0   
Iici 
<1.0
Isci 
>1.0   
Iici 
<1.0
Isci >1.0 
Iici >1.0
Isci <1.0 
Iici >1.0<1.0 >1.0 <1.0 >1.0
Control, 
n=10/100%
90.0 10.0 80.0 20.0 80.0 − 10.0 10.0
EC patients, 
n=24/100%
58.3 41.7 45.8 54.2 20.8 25.0 16.7 37.5
In contrast, only two women (20.0%) in control had 
increased sensitivity to bleomycin and one (10.0%) — 
hidden chromosome instability.
One more parameter, which shows chromosome 
instability, is presence of multi-aberrant cells being 
determined by number of CA per 1 aberrant cell. Be-
fore bleomycin impact, metaphases with two or more 
CA were determined in PBL of 33.3% of patients with 
EC, and after incubation of PBL with bleomycin — 
in 100.0% of EC patients. Due to this, after bleomycin 
effect, in PBL of all patients with EC, number of CA in-
creased as well as index of quantity of CA per 1 aber-
rant cell (at the mean up to 1.6) that was higher, than 
its values in control (1.2). Moreover, in PBL, after 
incubation with bleomycin, wide range of aberration 
forms has been observed — dicentric chromosomes, 
chromatid-chromatid exchanges arose (Fig. 2).
0 10 20 30 40 50 60
Spontaneous chromo-
somal instability
Increased sensitivity
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Hidden chromo-
somal instability
Number of cases, %
Control
EC patients
Fig. 1. Distribution of examined women (%) with spontaneous 
and hidden chromosome instability and increased sensitivity 
of chromosomes to the impact of bleomycin in PBL
a b c
Fig. 2. Fragments of metaphase plates with chromosome aber-
rations in PBL of EC patients after bleomycin impact: a) chroma-
tid-chromatid exchange and single acentric fragment; b) single 
and paired acentric fragments; c) dicentric chromosome with 
paired acentric fragment. Giemsa staining, ×1250 (oil immersion)
When carrying out study, we paid attention to the pre-
sence of “marker” chromosome in PBL of one patient 
(K., 61 years), with family history of cancer: brother — 
colorectal cancer, grandfather by mother’s side — pros-
tate cancer. After incubation with bleomycin, at ana lysis 
of 143 metaphases of this patient, large acrocentric 
“marker” chromosome, which was found with frequency 
2.1 per 100 cells, has been detected.
Though bleomycin is not referred to mutagens 
used for detection of chromosomal fragile sites (FS), 
but it is logically to suppose that after impact of this 
mutagen, CA occur, first of all, exactly in these parts 
of chromosomes.
At karyotype analysis, which was carried out 
at G-staining of metaphase chromosomes, we have 
determined in PBL of healthy women one FS, which 
has been detected on chromosome 2p15, but in the list 
of FS in this part no FS was registered [18]. At the same 
time, in PBL of two patients with EC, up before impact 
of bleomycin, nonrandom sites of chromosome da-
mage (in one patient in part 2p23, in second — 12q24) 
have been determined. After incubation with bleomy-
cin, in PBL of 40.0% of EC patients, increased fragility 
of chromosomes in certain sites, which by localization 
Experimental Oncology 36, 202–206, 2014 (September) 205
coincide with known FS of chromosomes 1, 2, 4, 5, 8, 
12 and 17: 1p32 (FRA1B); 1p36 (FRA1A); 1q31 (FRA1K); 
2p13 (FRA2B); 2q22–31 (FRA2F, FRA2G); 2qter 
(FRA2J); 4q31 (FRA4C); 5q13–15 (FRA5A, FRA5B); 
5q31 (FRA5C); 8q24 (FRA8C, FRA8D, FRA8E); 
12q13 (FRA12A) and 17р12-(FRA17A), has been 
determined [18]. Moreover, identification of genes 
in FS of chromosomes according to the NGNC da-
tabase, allowed us to determine that in these sites 
exactly or besides them, key genes of reparation and 
regulation of cellular cycle (1р3.2 — BLYM, MYCLI, 
TALI, JUN; 1q2.2–2.4 — SKI, 1q23-q31-TRKB, TRKC; 
2q3.3-qter — INHA; 4q3.1 — IL15; 5q2.1- q2.2 — АРС, 
5q2.1- q3.1 — СTNN1, etc.) are located. We should 
pay attention on determined damages of chromo-
some 12 in site 12p11-p13 — exactly in this part are 
located genes, which are connected with development 
(12p12.1 — KRAS2) and progression (12-q24.13 — 
C-MYC, 12p11-р14 — TFRβ, 12p13 — CDК2, CDК4) 
of EC  [19–22].
Obtained results of cytogenetic analysis can 
be the evidence of nonrandom nature of localization 
of chromosomal damages in PBL of patients with 
EC. Obtained results in certain measure coincide with 
results of other researchers, who have noticed four 
regions in chromosomes in PBL of patients with EC, 
in which FS were mostly found (1q2.4–3.1; 2q2.4–3.1; 
4q2.5–3.1; 5q2.3–3.2) [23].
Results of calculation of spontaneous and induced 
specific damageability of chromosomes from diffe-
rent karyotype groups in PBL of healthy women and 
EC patients are represented in Fig 3.
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Fig. 3. Comparison of spontaneous and bleomycin-induced 
specific damageability of chromosome damage of different 
karyotype groups in healthy women and in EC patients
Analysis of spontaneous frequency of CA in PBL 
of patients with EC has showed that the highest number 
of susceptible sites has been detected in chromosomes 
from groups E, C and A and in a smaller number — 
in groups B and D, and aberrations of chromosomes were 
not observed in groups F and G. In control, chromosomes 
of different groups have been damaged with almost equal 
frequency, except groups D and G, in which aberrations 
of chromosomes were not observed.
After bleomycin impact, specific damageability 
of chromosome has increased both in PBL of healthy 
women and in patients with EC. This damageability was 
significantly (р < 0.05) higher in groups A, B, C, E and, 
at the same time, induced damages in chromosomes 
from group F occurred. In general, in PBL of healthy 
individuals, specific damageability of chromosome af-
ter incubation of them with bleomycin was significantly 
(р < 0.05) lower, than in patients with EC and damages 
have been mostly observed in chromosomes of groups 
A and B.
At calculation of specific damageability of ge-
nome (Wgenome) of PBL, it has been determined that 
in patients with EC, spontaneous level of Wgenome has 
equaled 2•10–5, and after impact of bleomycin it has 
significantly (р < 0.05) increased in 4.5 times and has 
constituted 9•10–5. In PBL of healthy women, Wgenome 
has equaled 8•10–6, and after incubation with bleo-
mycin, it has increased only up to 1.0•10–5 (Table 3).
Table 3. Indexes of specific weight of chromosome damage (Wgenome) 
in PBL of healthy donors and patients with EC
Group of patients Level of WgenomeSpontaneous Bleomycin-induced
Control 8.0•10–6 1.0•10–5
EC patients 2.0•10–5* 9.0•10–5*
Note: *difference between indexes of EC patients and in control is signifi-
cant (р < 0.05).
Thus, results of cytogenetic study allowed us to de-
tect series of differences between indexes of chromo-
some instability in PBL of healthy women and in pa-
tients with EC, main of which is high sensitivity of PBL 
of EC patients to mutagenic action of bleomycin. It should 
be mentioned that during carrying out of antitumor treat-
ment (radio- and chemotherapy), detected high specific 
damageability of chromosome in patients with EC can 
cause progressive increase of genome destabilization 
and occurrence of secondary tumors.
It can be assumed that hypersensitivity of chromo-
somes of PBL of patients with EC to the effect of bleomy-
cin is not sporadic, but is conditioned by hereditary fac-
tors. This assumption can be confirmed by data of other 
authors, who have showed that sensitivity of PBL to the 
effect of mutagens is genetically determined. In particu-
lar, differences in sensitivity of chromosomes to bleo-
mycin of PBL of mono- and dizygotic twins have been 
determined [24]. Moreover, it has been demonstrated 
in series of studies that increased sensitivity of PBL 
to the effect of genotoxic agents is indicator of genetic 
predisposition of such individuals to cancer [7, 16, 24]. 
At the same time, it is known that at simultaneous impact 
of radioactive and chemical factors on organism (envi-
ronment of the most populations in urbanized countries), 
they are able to perform both additive and multiplicative 
effect, and peculiarities of cumulative action of genetic 
and environmental factors is increase of multiplicative 
effect [9]. Since exactly genetic mechanisms determine 
differences in people’s reactions to the impact of harmful 
factors, it can be assumed that presence of genetically 
determined genome instability is one of the key reasons 
of EC, which has been realized in the harmful conditions 
of environment. Thus, determination of spontaneous and 
bleomycin-induced level of CA in PBL helps us to detect 
individuals with high level of genome destabilization 
and high sensitivity to genotoxic environmental factors. 
It indicates the necessity of carrying out cytogenetic 
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examination in EC patients, and, on the condition of he-
reditary nature of disease, also in their female relatives 
with the aim to detect individuals with high risk of cancer 
among them.
Therefore, our findings indicate that PBL of most 
patients with EC are characterized by apparent genome 
destabilization, which has individual peculiarities and 
is manifested by increased number of spontaneous and 
induced damages of chromosomes, hypersensitivity 
to the impact of mutagenic factors and hidden chromo-
somal instability. Sites of high fragility, which were de-
tected in chromosomes of PBL of EC patients, by their 
localization coincide with known FS of chromosomes, 
arrangement of some genes-suppressors, proto- and 
oncogenes, including genes involved in malignant 
transformation of endometrial cells, and with some sites 
of chromosomal damages, which are detected in tumor 
cells of endometrium. Cytogenetic study of PBL has 
clinical significance for detection of individual indica-
tors being genetic markers of genome instability that 
must be taken into account while carrying out antitumor 
treatment of patients.
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